Detailed answers about CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD, including incorporation, status, business activity, and accounts information.
When was CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD founded?
CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD was officially incorporated on 23 June 2021 and is registered under company number 13474132. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD?
CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD do?
CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD operates in the following sector: 47741 - Retail sale of hearing aids. This provides insight into the company's primary business activity and industry focus.
What is CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD's registered address?
The registered office address of CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD is UNIT 317, INDIA MILLS BUSINESS CENTRE, DARWEN, LANCASHIRE, UNITED KINGDOM, BB3 1AE. This is the official address filed with Companies House for legal and statutory correspondence.
Is CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD financially stable?
The most recent accounts for CHELTENHAM AND GLOUCESTER HEARING CLINIC LTD were made up to 30 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.